Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A (GABA_A) receptor alpha-1 beta-gamma subtype is a pentameric ligand-gated ion channel that serves as the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system (Olsen & Sieghart, 2008). This specific subtype, typically composed of α1, β2/3, and γ2 subunits, is the most prevalent GABA_A receptor isoform in the brain, particularly concentrated in the cerebral cortex, hippocampus, and cerebellum (Sigel & Steinmann, 2012). It functions by conducting chloride ions across the neuronal membrane upon GABA binding, leading to hyperpolarization and decreased neuronal firing. The α1-containing receptors are notably characterized by their high affinity for benzodiazepines and non-benzodiazepine hypnotics (Z-drugs), which bind at the α1-γ2 subunit interface (Tan et al., 2011). Pharmacological targeting of this subtype is central to the treatment of insomnia and epilepsy, as it mediates the sedative, hypnotic, and anticonvulsant properties of these agents (Rudolph & Knoflach, 2011). However, chronic modulation can lead to side effects such as tolerance, dependence, and cognitive impairment.
Positive allosteric modulation of the GABA-A receptor, which increases the frequency of chloride channel opening in response to GABA binding, thereby enhancing inhibitory postsynaptic potentials (Sigel & Steinmann, 2012).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-1 beta-gamma subtype (GABA_A receptor α1βγ).